16.93
price up icon3.87%   0.63
after-market アフターアワーズ: 16.80 -0.13 -0.77%
loading
前日終値:
$16.30
開ける:
$16.81
24時間の取引高:
261.66K
Relative Volume:
0.74
時価総額:
$625.78M
収益:
$11.88M
当期純損益:
$-162.08M
株価収益率:
-1.3561
EPS:
-12.484
ネットキャッシュフロー:
$-156.43M
1週間 パフォーマンス:
+12.49%
1か月 パフォーマンス:
-8.78%
6か月 パフォーマンス:
+50.22%
1年 パフォーマンス:
+27.39%
1日の値動き範囲:
Value
$16.48
$17.80
1週間の範囲:
Value
$15.44
$17.80
52週間の値動き範囲:
Value
$8.72
$27.41

Crescent Biopharma Inc Stock (CBIO) Company Profile

Name
名前
Crescent Biopharma Inc
Name
セクター
Healthcare (1074)
Name
電話
617-430-5595
Name
住所
300 FIFTH AVENUE, WALTHAM, CA
Name
職員
44
Name
Twitter
@catalystbio
Name
次回の収益日
2026-07-30
Name
最新のSEC提出書
Name
CBIO's Discussions on Twitter

Compare CBIO vs VRTX, REGN, ARGX, RVMD, ALNY

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
CBIO icon
CBIO
Crescent Biopharma Inc
16.93 602.49M 11.88M -162.08M -156.43M -12.48
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
479.00 121.16B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
667.17 68.78B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
888.82 57.44B 4.16B 1.29B 734.26M 19.58
RVMD icon
RVMD
Revolution Medicines Inc
188.07 40.23B 742.00K -1.37B -1.07B -7.0731
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
278.40 36.28B 4.29B 577.22M 641.34M 4.2086

Crescent Biopharma Inc Stock (CBIO) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-01-28 開始されました Piper Sandler Overweight
2026-01-21 開始されました Guggenheim Buy
2025-08-25 開始されました Jefferies Buy
2025-08-11 開始されました H.C. Wainwright Buy
2025-07-14 開始されました Wedbush Outperform
2025-06-25 開始されました Stifel Buy
2025-03-21 開始されました Cantor Fitzgerald Overweight
2025-03-11 開始されました Noble Capital Markets Outperform
2024-07-26 ダウングレード TD Cowen Buy → Hold
2023-12-22 開始されました CapitalOne Overweight
2021-11-12 アップグレード Jefferies Hold → Buy
2021-04-29 再開されました Stephens Overweight
2021-02-10 開始されました Piper Sandler Overweight
2020-05-21 開始されました Raymond James Outperform
2019-11-14 開始されました ROTH Capital Buy
2019-08-05 ダウングレード Jefferies Buy → Hold
2019-08-05 ダウングレード Piper Jaffray Overweight → Neutral
2019-08-05 ダウングレード SunTrust Buy → Hold
2019-04-12 開始されました Piper Jaffray Overweight
2019-01-04 開始されました Oppenheimer Outperform
2018-12-18 開始されました H.C. Wainwright Buy
2018-02-12 繰り返されました B. Riley FBR, Inc. Buy
2018-02-09 繰り返されました Chardan Capital Markets Buy
2017-12-08 開始されました B. Riley FBR, Inc. Buy
2017-06-12 開始されました Chardan Capital Markets Buy
2017-06-06 開始されました Ladenburg Thalmann Buy
2016-07-26 開始されました SunTrust Buy
2016-06-30 開始されました Rodman & Renshaw Buy
2015-03-17 繰り返されました Stifel Buy
すべてを表示

Crescent Biopharma Inc (CBIO) 最新ニュース

pulisher
Jul 27, 2026

Crescent Biopharma Ord Shs (CBIO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Crescent Biopharma Market Sentiment - Benzinga España

Jul 27, 2026
pulisher
Jul 25, 2026

CBIO|Crescent Biopharma Ord Shs|Price:16.300|Chg%:-0.730 - TradingKey

Jul 25, 2026
pulisher
Jul 24, 2026

Crescent Biopharma (CBIO) Short Interest & Short Float | Updated Jul 2026 - MarketBeat

Jul 24, 2026
pulisher
Jul 23, 2026

Crescent Biopharma grants inducement stock options for 52,500 shares at $15.83 each - Bitget

Jul 23, 2026
pulisher
Jul 23, 2026

Crescent Biopharma Announces Grants of Inducement Awards - The Manila Times

Jul 23, 2026
pulisher
Jul 23, 2026

Two Crescent Biopharma Employees Receive 52,500 Stock Options - Stock Titan

Jul 23, 2026
pulisher
Jul 20, 2026

Fairmount Healthcare Fund II LP acquires 853,450 Crescent Biopharma shares for $12.38 million - Bitget

Jul 20, 2026
pulisher
Jul 20, 2026

Fairmount Funds' $12 Million Bet on Crescent Biopharma: A Strong Signal Amidst Volatility - Kavout | AI

Jul 20, 2026
pulisher
Jul 20, 2026

Insider fund at Crescent Biopharma (NASDAQ: CBIO) buys 1.38M shares, warrants - Stock Titan

Jul 20, 2026
pulisher
Jul 20, 2026

Fairmount Funds holds 16.5% of Crescent Biopharma (CBIO) after July 2026 deal - Stock Titan

Jul 20, 2026
pulisher
Jul 17, 2026

Analysts Offer Insights on Healthcare Companies: RxSight (RXST), Kazia Therapeutics (KZIA) and Crescent Biopharma (CBIO) - The Globe and Mail

Jul 17, 2026
pulisher
Jul 17, 2026

Crescent Biopharma (CBIO) Jefferies Global Healthcare Conference 2026 Summary - Quartr

Jul 17, 2026
pulisher
Jul 16, 2026

Crescent Biopharma closes $143.7 million public offering - Investing.com

Jul 16, 2026
pulisher
Jul 16, 2026

Crescent Biopharma closes $143.7 million public offering By Investing.com - Investing.com Nigeria

Jul 16, 2026
pulisher
Jul 16, 2026

Crescent Biopharma (CBIO) Proxy filing Summary - Quartr

Jul 16, 2026
pulisher
Jul 16, 2026

Crescent Biopharma Announces Closing of Public Offering of - GlobeNewswire

Jul 16, 2026
pulisher
Jul 16, 2026

Crescent Biopharma (CBIO) Bank of America Global Healthcare Conference 2026 Summary - Quartr

Jul 16, 2026
pulisher
Jul 16, 2026

H.C. Wainwright Maintains Crescent Biopharma(CBIO.US) With Hold Rating - Moomoo

Jul 16, 2026
pulisher
Jul 16, 2026

Crescent Biopharma closes $143.7M public offering - scanx.trade

Jul 16, 2026
pulisher
Jul 15, 2026

Form 424B5 Crescent Biopharma Inc For: 15 July By Investing.com - Investing.com Canada

Jul 15, 2026
pulisher
Jul 15, 2026

Crescent Bi raises up to $133.5M in registered offering of 8.09M shares and pre-funded warrants - TradingView

Jul 15, 2026
pulisher
Jul 15, 2026

Crescent Biopharma (Nasdaq: CBIO) prices $125.0 million stock and warrant sale - Stock Titan

Jul 15, 2026
pulisher
Jul 15, 2026

Form 424B5 CRESCENT BIOPHARMA, INC. - StreetInsider

Jul 15, 2026
pulisher
Jul 15, 2026

Crescent Biopharma (Nasdaq: CBIO) targets approximately $115.9 million raise - Stock Titan

Jul 15, 2026
pulisher
Jul 15, 2026

Crescent Biopharma Prices $125 Million Common, Warrant Offering - marketscreener.com

Jul 15, 2026
pulisher
Jul 15, 2026

Crescent Biopharma Announces Pricing of Public Offering of Ordinary Shares and Pre-Funded Warrants - The Manila Times

Jul 15, 2026
pulisher
Jul 15, 2026

Crescent Biopharma, Inc. Files 8-K with SEC – Ordinary Shares (CBIO) Listed on NASDAQ, Key Company Details for July 2026 141649 – Minichart - Minichart

Jul 15, 2026
pulisher
Jul 14, 2026

Form 424B5 Crescent Biopharma Inc For: 14 July - Investing.com UK

Jul 14, 2026
pulisher
Jul 14, 2026

Crescent Biopharma launches public offering of ordinary shares By Investing.com - Investing.com Nigeria

Jul 14, 2026
pulisher
Jul 14, 2026

Crescent Biopharma prices $125M public offering at $14.50/share - Investing.com

Jul 14, 2026
pulisher
Jul 14, 2026

Crescent Biopharma Underwriters Have Option for Nearly 1.3M Additional Shares >CBIO - Moomoo

Jul 14, 2026
pulisher
Jul 14, 2026

Crescent Biopharma prices $125M public offering of shares and pre-funded warrants - Pluang

Jul 14, 2026
pulisher
Jul 14, 2026

Crescent Biopharma Expects Offering to Close July 16 >CBIO - Moomoo

Jul 14, 2026
pulisher
Jul 14, 2026

Crescent Biopharma Also Offering Certain Investors Prefunded Warrants to Buy 525,897 Shares >CBIO - Moomoo

Jul 14, 2026
pulisher
Jul 14, 2026

Crescent Biopharma prices $125M public offering at $14.50/share By Investing.com - Investing.com India

Jul 14, 2026
pulisher
Jul 14, 2026

Crescent Biopharma Prices $125 Million Public Offering of Ordinary Shares and Pre-Funded Warrants - Quiver Quantitative

Jul 14, 2026
pulisher
Jul 14, 2026

Crescent Biopharma Sets $14.50 Price for 8.1M Shares - Stock Titan

Jul 14, 2026
pulisher
Jul 14, 2026

Crescent Biopharma files for underwritten offering of ordinary shares and pre-funded warrants - MSN

Jul 14, 2026
pulisher
Jul 14, 2026

Crescent Biopharma launches public offering of ordinary shares - Investing.com

Jul 14, 2026
pulisher
Jul 14, 2026

Crescent Biopharma Launches Offering of Common Shares, Warrants - marketscreener.com

Jul 14, 2026
pulisher
Jul 14, 2026

Form 424B5 Crescent Biopharma Inc For: 14 July By Investing.com - Investing.com India

Jul 14, 2026
pulisher
Jul 14, 2026

Crescent Biopharma Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants - The Manila Times

Jul 14, 2026
pulisher
Jul 14, 2026

Crescent Biopharma (NASDAQ: CBIO) reports $171.6M preliminary cash as of June 30, 2026 - Stock Titan

Jul 14, 2026
pulisher
Jul 14, 2026

Crescent Biopharma (NASDAQ: CBIO) details share and pre-funded warrant deal - Stock Titan

Jul 14, 2026
pulisher
Jul 14, 2026

Price to earnings forward of Crescent Biopharma, Inc. – NASDAQ:CBIO - TradingView

Jul 14, 2026
pulisher
Jul 14, 2026

symbol__ Stock Quote Price and Forecast - CNN

Jul 14, 2026
pulisher
Jul 13, 2026

[EFFECT] CRESCENT BIOPHARMA, INC. SEC Filing - Stock Titan

Jul 13, 2026
pulisher
Jul 11, 2026

Crescent Biopharma Inc (CBIO) - MSN

Jul 11, 2026
pulisher
Jul 08, 2026

Crescent Biopharma (CBIO) Morgan Stanley 23rd Annual Global Healthcare Conference summary - Quartr

Jul 08, 2026
pulisher
Jul 06, 2026

Enterprise value to EBITDA forward of Crescent Biopharma, Inc. – NASDAQ:CBIO - TradingView

Jul 06, 2026

Crescent Biopharma Inc (CBIO) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$91.09
price up icon 1.97%
$118.87
price up icon 1.02%
$34.72
price down icon 0.83%
$58.73
price down icon 0.17%
ONC ONC
$325.90
price up icon 0.00%
$278.40
price up icon 2.44%
大文字化:     |  ボリューム (24 時間):